DLGAP1-AS2

Across TCGA pan-cancer cohorts, DLGAP1-AS2 RNA differs between tumor and matched normal tissue in 14 of 18 cancer types tested, making tumor–normal expression one of DLGAP1-AS2’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where DLGAP1-AS2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types DLGAP1-AS2 is over-expressed in tumor, although a few such as KIRC and KICH show the opposite, repressed pattern.

COAD, HNSC, and LIHC are the cancer types where DLGAP1-AS2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in DLGAP1-AS2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	All	+1.570	<.001	11	view →
HNSC	Male	III,IV	+1.225	<.001	11	view →
LIHC	All	III,IV	+0.671	<.001	9	view →
THCA	All	All	+0.475	<.001	9	view →
KIRC	All	II,III,IV	−0.445	<.001	8	view →
READ	All	All	+1.792	<.001	7	view →
STAD	Male	II,III,IV	+1.471	<.001	7	view →
CHOL	Male	All	+2.571	<.001	5	view →
LUAD	All	II,III,IV	+0.838	<.001	5	view →
BLCA	All	III,IV	+0.732	.015	5	view →
LUSC	Male	All	+0.701	<.001	5	view →
KICH	All	All	−0.898	.001	4	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 14 lineages.

DLGAP1-AS2–COAD

Open the COAD breakdown →